Ethernovia is focused on creating an advanced Ethernet system capable of meeting the increasing bandwidth demands of modern vehicle integration. By unifying vehicle networks, Ethernovia's technology significantly influences automotive design and manufacturing processes. The system incorporates features such as autonomous expansions, enhanced security intelligence, and optimized sensor bandwidths, allowing clients to innovate and develop vehicles more effectively. Through its sophisticated approach, Ethernovia aims to redefine how cars are architected, ultimately contributing to the evolution of the automotive industry.
Light Field Lab, Inc. is a technology startup focused on developing holographic capture display systems. Founded in 2017 and based in San Jose, California, the company creates innovative solutions that generate three-dimensional holographic images that can be viewed from multiple angles without the need for head-mounted devices. Its technology aims to project 3D holograms into living spaces, allowing users to experience immersive visuals that respond dynamically to their viewpoint. Additionally, Light Field Lab offers integrated processing and imaging solutions designed to deliver these visuals over commercial network speeds. The company is also working on a universal application programming interface to facilitate the adaptation of existing content for its holographic displays. With a mission to enable a holographic future, Light Field Lab seeks to unlock new business opportunities across both consumer and enterprise markets.
Cognito Health focuses on enhancing the healthcare environment by delivering value to both patients and healthcare systems. The company has developed a global healthcare device that employs predictive algorithms to monitor patients continuously, providing a data-driven, contact-free solution. This technology alerts healthcare professionals to potential patient safety issues before they arise, such as the need for repositioning to prevent pressure-related injuries. By visually mapping pressure points, Cognito Health enables clinicians to respond proactively, improving patient outcomes and optimizing care delivery.
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.
Avesha is a technology platform that specializes in enhancing application workloads across cloud, multi-cloud, and edge environments. Founded in 2019 and headquartered in Burlington, Massachusetts, the company offers a solution that improves business outcomes by facilitating automation and enabling high-performance, low-latency applications. Avesha's software simplifies the visibility and segmentation of applications across various clusters, which aids in security, resiliency, and overall quality of experience. Its Smart Network Application Platform (SNAP) creates a virtual overlay on any underlying network, allowing enterprises to efficiently distribute data and application logic closer to end-users. This capability supports multi-cloud deployments and real-time applications, making it a valuable tool for organizations seeking to optimize their application infrastructure.
FIGUR8, Inc. is a Boston-based company established in 2016 that specializes in manufacturing wearable sensors designed to measure body movement as a biomarker for musculoskeletal-related conditions. The company also offers a platform that tracks and analyzes musculoskeletal health data, aiming to provide insights into human movement. Founded by a team of engineers, researchers, and designers with backgrounds in wearable computing, digital health, and sports science, FIGUR8 focuses on making advanced movement analysis accessible to a broader audience, moving beyond the elite users to everyday individuals.
Verana Networks develops an innovative 5G Radio Access Network solution for service providers that have licensed millimeter wave (mmWave) spectrum.
The company focuses on enabling 5G in mmWave spectrum because that is where the largest amount of new spectrum is. For 5G to succeed, it must deliver a 10X-50X increase in speed and capacity. Blazing fast speed and an increase in capacity enable new applications, these new applications create incremental revenue, and incremental revenue is essential to support the business case for 5G.
Nanolive SA is a Swiss company that specializes in the design and development of advanced devices for scanning living cells. Established in 2013 and headquartered in Ecublens, the company has created the 3D Cell Explorer, a technology that allows researchers to visualize the interior of living cells in three dimensions without the need for labeling or invasive techniques. This device is capable of examining various cellular processes, including cell division, organelle function, morphology, differentiation, and interactions between cells. Nanolive's technology is particularly valuable in drug monitoring and in vitro fertilization, providing crucial insights for researchers in the fields of drug development and therapeutic discovery. The company's innovative approach aims to enhance the understanding of cellular dynamics, ultimately contributing to advancements in medical research and treatment.
Light Field Lab, Inc. is a technology startup focused on developing holographic capture display systems. Founded in 2017 and based in San Jose, California, the company creates innovative solutions that generate three-dimensional holographic images that can be viewed from multiple angles without the need for head-mounted devices. Its technology aims to project 3D holograms into living spaces, allowing users to experience immersive visuals that respond dynamically to their viewpoint. Additionally, Light Field Lab offers integrated processing and imaging solutions designed to deliver these visuals over commercial network speeds. The company is also working on a universal application programming interface to facilitate the adaptation of existing content for its holographic displays. With a mission to enable a holographic future, Light Field Lab seeks to unlock new business opportunities across both consumer and enterprise markets.
Developer of a content management system designed to manage data between teams and customers in a single framework. The company's content management system allows users to manage, audit, analyze and share data within a unified platform, enabling clients with a consolidated view of data across the organization.
Pavilion Data Systems Inc. specializes in the design and development of NVMe-over-Fabric storage platforms that cater to massively-parallel applications. The company offers innovative solutions, including OPENCHOICE, which revolutionizes traditional storage procurement and deployment methods, and Pavilion Data OS, enabling Internet and SaaS companies, cloud service providers, and enterprises to efficiently manage critical applications. Pavilion's products deliver exceptional storage performance and density while avoiding the complexities associated with legacy all-flash arrays. By utilizing Hyperparallel Flash Arrays, which incorporate multiple controllers to maximize the advantages of flash technology, Pavilion achieves ultra-low latency and linear scalability, addressing the growing demand for enhanced data throughput across various sectors, including financial services, government, media, and research. Founded in 2011 and headquartered in San Jose, California, Pavilion Data Systems also maintains offices in Schiphol, the Netherlands, and Pune, India.
Windgap Medical Inc. is a biotechnology company that specializes in the manufacture of compact epinephrine autoinjectors designed for the treatment of anaphylaxis, a severe allergic reaction. Established in 2011, the company is headquartered in Watertown, Massachusetts. Windgap Medical's innovative auto-injectors are filled with heat-stable epinephrine, which enhances the temperature resilience and shelf life of the medication. This feature allows healthcare providers to effectively administer epinephrine to patients experiencing acute allergy attacks, improving their chances of recovery during critical moments.
Appaegis simplifies enterprise data access while enforcing strong zero-trust security for remote access. Its patent-pending solution protects data access and gives administrators full control over how enterprise data is used. The company was founded by security veterans with successful security track records.
Landing AI is a company that specializes in artificial intelligence transformation programs tailored for the manufacturing industry. Founded in 2017 and based in Palo Alto, California, the company develops solutions focused on visual inspection, automation, calibration, and automated issue identification. Its offerings cater to a diverse range of sectors, including manufacturing, retail, automotive, agriculture, telecommunications, and pharmaceuticals. The company aims to empower organizations to become AI-driven by providing a platform that enhances the accuracy of machine learning models through effective data generation and labeling. This platform helps identify environmental issues and alerts users to model changes, thereby facilitating efficient data management and accelerating troubleshooting processes. Founded by Dr. Andrew Ng, a prominent figure in AI, Landing AI is positioned to deliver practical AI solutions that drive value for businesses globally.
Ethernovia is focused on creating an advanced Ethernet system capable of meeting the increasing bandwidth demands of modern vehicle integration. By unifying vehicle networks, Ethernovia's technology significantly influences automotive design and manufacturing processes. The system incorporates features such as autonomous expansions, enhanced security intelligence, and optimized sensor bandwidths, allowing clients to innovate and develop vehicles more effectively. Through its sophisticated approach, Ethernovia aims to redefine how cars are architected, ultimately contributing to the evolution of the automotive industry.
Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
AEye, Inc. specializes in developing vision hardware, software, and algorithms tailored for autonomous vehicles. The company is known for its innovative iDAR platform, which integrates LiDAR, computer vision, and artificial intelligence to enhance perception and motion planning for advanced driver assistance systems (ADAS) and autonomous vehicles. AEye's product offerings include the 4Sight A and 4Sight M sensors, as well as the AE100 Robotic Perception System and AE200, which are designed to meet the demands of the mobility market with modular and high-performance features. Since its inception in 2013 and a name change in 2016, AEye has established itself as a leader in intelligent sensing technology, securing investment from prestigious firms such as Kleiner Perkins and Intel Capital. The company is headquartered in Dublin, California, within the San Francisco Bay Area.
SafeLiShare is a developer of data security software designed to assist enterprises in securely publishing and sharing sensitive data and programmatic assets. The company's technology enables organizations to safely utilize and share their valuable digital assets, facilitating the generation of business insights, machine learning, and other analytics on sensitive information. By providing a platform that allows clients to unlock new revenue streams and derive insights from their sensitive data, SafeLiShare addresses the challenges faced by enterprises in managing and leveraging their private information effectively.
Kdan Mobile Software Ltd. is a global company that specializes in mobile software applications and online services, aimed at enhancing productivity and creativity. Founded in 2009 and headquartered in Tainan City, Taiwan, the company has expanded its presence with offices in Taipei, Huntingdon, Changsha, Beijing, and Tokyo. Kdan Mobile offers a variety of solutions, including Creativity 365, a comprehensive content creation suite featuring applications such as Animation Desk and Write-on Video, and Document 365, which provides tools for document management, including a PDF reader and online converting services. Other notable offerings include Kdan Cloud, a collaborative workspace, DottedSign for eSignature management, and Kdan PDF SDK for developers. Additionally, Kdan Mobile features My Markups for web page sharing and AniZone for video publishing and interaction. With over 200 million downloads globally, Kdan Mobile serves a diverse clientele, empowering users to create, distribute, and manage their projects effectively across various digital platforms.
FIGUR8, Inc. is a Boston-based company established in 2016 that specializes in manufacturing wearable sensors designed to measure body movement as a biomarker for musculoskeletal-related conditions. The company also offers a platform that tracks and analyzes musculoskeletal health data, aiming to provide insights into human movement. Founded by a team of engineers, researchers, and designers with backgrounds in wearable computing, digital health, and sports science, FIGUR8 focuses on making advanced movement analysis accessible to a broader audience, moving beyond the elite users to everyday individuals.
Arris Composites, Inc. is an industrial engineering company that specializes in the development and manufacture of carbon fiber composites for mass-market applications. Founded in 2017 and based in Berkeley, California, the company focuses on sectors such as aerospace, automotive, and consumer products. Arris Composites is known for its innovative manufacturing process that allows for the precise alignment of continuous carbon fibers, as well as the integration of electronic components and multifunctional materials into a single, optimized part. This technology enables clients to utilize advanced composites that enhance performance and efficiency in various applications.
Oculii is an advanced radar sensor developer specializing in 4D radar design and fusion. 4D sensors have traditionally been the domain of high power, expensive military grade radar or laser systems. Backed by top-tier Silicon Valley angel investors and VCs - they've turned this paradigm on its head, leveraging advanced sensor fusion techniques to manufacture smarter, high precision sensors and systems. Their technology allows us to extract unprecedented accuracy, range, and 4D positioning information from commodity off the shelf low-cost radar elements, bringing high resolution radar imaging to the next frontier.
Oculii is an advanced radar sensor developer specializing in 4D radar design and fusion. 4D sensors have traditionally been the domain of high power, expensive military grade radar or laser systems. Backed by top-tier Silicon Valley angel investors and VCs - they've turned this paradigm on its head, leveraging advanced sensor fusion techniques to manufacture smarter, high precision sensors and systems. Their technology allows us to extract unprecedented accuracy, range, and 4D positioning information from commodity off the shelf low-cost radar elements, bringing high resolution radar imaging to the next frontier.
Enable objects to wirelessly communicate valuable information to its users
Enable objects to wirelessly communicate valuable information to its users
Suono Bio, Inc. is focused on developing a novel platform technology for the rapid and localized delivery of therapeutic products, specifically targeting the gastrointestinal (GI) tract. Incorporated in 2016 and based in Medford, Massachusetts, the company aims to facilitate the administration of small molecules, proteins, vaccines, and nucleic acids without the need for encapsulation. Preclinical studies have shown the platform's effectiveness in delivering various therapeutics both locally and systemically, which supports its potential for treating inflammatory-mediated diseases. This innovative approach may offer significant advancements in therapeutic delivery, enhancing patient recovery from gastrointestinal conditions.
Avesha is a technology platform that specializes in enhancing application workloads across cloud, multi-cloud, and edge environments. Founded in 2019 and headquartered in Burlington, Massachusetts, the company offers a solution that improves business outcomes by facilitating automation and enabling high-performance, low-latency applications. Avesha's software simplifies the visibility and segmentation of applications across various clusters, which aids in security, resiliency, and overall quality of experience. Its Smart Network Application Platform (SNAP) creates a virtual overlay on any underlying network, allowing enterprises to efficiently distribute data and application logic closer to end-users. This capability supports multi-cloud deployments and real-time applications, making it a valuable tool for organizations seeking to optimize their application infrastructure.
Viracta Therapeutics specializes in developing innovative treatments for cancers linked to the Epstein-Barr Virus. The company is advancing its proprietary viral gene activation therapy, which aims to effectively target and address these virus-associated malignancies. In addition to its primary focus on Epstein-Barr Virus-related cancers, Viracta is also exploring opportunities to tackle other serious diseases associated with viral infections. Through its research and therapeutic advancements, the company seeks to improve outcomes for patients suffering from these challenging health conditions.
Ambiq Micro
Series F in 2020
Ambiq Micro is an early-stage fabless semiconductor company that is developing ultra-low-power mixed-signal solutions for a new generation of wireless electronics. Ambiq Micro was founded in 2010 on the simple yet powerful notion that extremely low-power semiconductors are the key to the future of electronics. Through the use of their pioneering ultra-low-power technology, they help innovative companies around the world develop differentiated solutions that reduce or eliminate the need for batteries, lower overall system power, and maximize industrial design flexibility.
Ushering in an age of data-driven technology Artilux Connect Series provides complete IC solutions featuring high performance with competitive cost for various optical connectivity applications. Our product portfolios cover short range 10-40G consumer usages, to long range 100G data center links. We embed advanced optical and RF technology into every wire to enable seamless and instant data transfer in our living room or up in the cloud.
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.
C4 is building on the knowledge with synthetic chemical compounds which it calls Degronimids. These compounds can be engineered and linked together to bind with many molecular targets that today’s drugs can’t bind with, Cohen said. The key insight, he said, is that the scientific founders have discovered a way to bind with select disease-causing proteins, and flag them as cellular trash, so that the ordinary proteasome garbage disposal system can get rid of them. Selecting the precise disease-related proteins to send to the trash is obviously critical, because any drug like this could cause serious side effects if it sent healthy proteins involved in normal cell processes to the trash. C4 Therapeutics is developing a new class of targeted protein degradation (TPD) therapeutics for the treatment of a broad range of diseases. Our Degronimid™ platform incorporates highly selective small molecule binders to target disease-causing proteins and facilitate their rapid destruction and clearance from the cell through the natural ubiquitin/proteasome system (UPS). Because of this distinctive mechanism, Degronimids are capable of hitting many more targets, including those previously thought to be undruggable, while reducing the potential for drug resistance. The broad applicability of Degronimids, and our chemical biology platform designed for accelerated validation, have the potential to make an unprecedented impact across many diseases through multiple industry collaborations as well as proprietary programs. The Company has received an exclusive worldwide license to the Degronimid platform and related IP from Dana-Farber.
Arris Composites, Inc. is an industrial engineering company that specializes in the development and manufacture of carbon fiber composites for mass-market applications. Founded in 2017 and based in Berkeley, California, the company focuses on sectors such as aerospace, automotive, and consumer products. Arris Composites is known for its innovative manufacturing process that allows for the precise alignment of continuous carbon fibers, as well as the integration of electronic components and multifunctional materials into a single, optimized part. This technology enables clients to utilize advanced composites that enhance performance and efficiency in various applications.
Regenacy Pharmaceuticals, LLC is a biopharmaceutical company based in Boston, Massachusetts, established in 2016. The company focuses on developing innovative treatments for peripheral neuropathies, hemoglobinopathies, and specific oncology indications. Its primary compound, ricolinostat, is an oral, selective inhibitor of the enzyme HDAC6, aimed at restoring normal nerve function rather than merely managing pain and symptoms. Currently positioned to enter Phase 2 clinical trials, ricolinostat shows promise for treating various forms of peripheral neuropathy, including diabetic, chemotherapy-induced, and inherited types, supported by preclinical studies that demonstrate its ability to regenerate normal protein function. Additionally, the company is exploring the potential applications of ricolinostat in treating sickle cell disease and beta-thalassemia.
Landing AI is a company that specializes in artificial intelligence transformation programs tailored for the manufacturing industry. Founded in 2017 and based in Palo Alto, California, the company develops solutions focused on visual inspection, automation, calibration, and automated issue identification. Its offerings cater to a diverse range of sectors, including manufacturing, retail, automotive, agriculture, telecommunications, and pharmaceuticals. The company aims to empower organizations to become AI-driven by providing a platform that enhances the accuracy of machine learning models through effective data generation and labeling. This platform helps identify environmental issues and alerts users to model changes, thereby facilitating efficient data management and accelerating troubleshooting processes. Founded by Dr. Andrew Ng, a prominent figure in AI, Landing AI is positioned to deliver practical AI solutions that drive value for businesses globally.
AEye, Inc. specializes in developing vision hardware, software, and algorithms tailored for autonomous vehicles. The company is known for its innovative iDAR platform, which integrates LiDAR, computer vision, and artificial intelligence to enhance perception and motion planning for advanced driver assistance systems (ADAS) and autonomous vehicles. AEye's product offerings include the 4Sight A and 4Sight M sensors, as well as the AE100 Robotic Perception System and AE200, which are designed to meet the demands of the mobility market with modular and high-performance features. Since its inception in 2013 and a name change in 2016, AEye has established itself as a leader in intelligent sensing technology, securing investment from prestigious firms such as Kleiner Perkins and Intel Capital. The company is headquartered in Dublin, California, within the San Francisco Bay Area.
Metanoia Communications Inc., established in 2004 and based in Hsinchu City, Taiwan, specializes in the development of semiconductor and software solutions for the wireline broadband and in-home networking markets. The company manufactures high-speed PHY chipsets, including products for VDSL2, G.fast, and G.hn technologies. With a focus on state-of-the-art system architecture and algorithm expertise, Metanoia delivers a diverse range of fixed-line communication products designed to meet the needs of broadband manufacturers. As a subsidiary of ELAN Microelectronics Corporation, Metanoia combines extensive integrated circuit design capabilities with innovative technology to support the growing demand for high-speed broadband connectivity.
DSP Concepts Inc. specializes in developing audio tools and intellectual property for creators of audio-enabled products. The company offers Audio Weaver, a versatile audio processing engine designed for embedded systems, featuring a library of audio building blocks for various applications. In addition, it provides TalkTo, a suite of machine learning and microphone processing algorithms that enhance audio quality in challenging environments. DSP Concepts also delivers software solutions, such as an asynchronous sample rate converter for devices with multiple audio input and output streams. Its services extend to design and consulting, automotive audio design and tuning, and custom internet protocol development. The company's clientele includes notable industry leaders in automotive, smart home, and entertainment sectors. Founded in 2003 and headquartered in Santa Clara, California, DSP Concepts has additional offices in Massachusetts, Germany, and China.
Tripresso is an online travel agent (OTA) mainly focus on package tour products. It started off by offering an online marketplace for package tour suppliers such as Lions Travel and Richmond, and it also builds a simple search engine for end customers to find suitable products. After that, it expands the product scope to hotels, flight tickets, and customized travel plans for outbound travel. In 2018, Tripresso launched a proprietary software-as-a-service (SaaS) system, TripSaaS, which allows brick-and-mortar travel agencies to manage websites, list products, and manage orders and customer relationships to enhance operational efficiency. The company was founded in 2013 in Taipei, Taiwan.
Viracta Therapeutics specializes in developing innovative treatments for cancers linked to the Epstein-Barr Virus. The company is advancing its proprietary viral gene activation therapy, which aims to effectively target and address these virus-associated malignancies. In addition to its primary focus on Epstein-Barr Virus-related cancers, Viracta is also exploring opportunities to tackle other serious diseases associated with viral infections. Through its research and therapeutic advancements, the company seeks to improve outcomes for patients suffering from these challenging health conditions.
Pavilion Data Systems Inc. specializes in the design and development of NVMe-over-Fabric storage platforms that cater to massively-parallel applications. The company offers innovative solutions, including OPENCHOICE, which revolutionizes traditional storage procurement and deployment methods, and Pavilion Data OS, enabling Internet and SaaS companies, cloud service providers, and enterprises to efficiently manage critical applications. Pavilion's products deliver exceptional storage performance and density while avoiding the complexities associated with legacy all-flash arrays. By utilizing Hyperparallel Flash Arrays, which incorporate multiple controllers to maximize the advantages of flash technology, Pavilion achieves ultra-low latency and linear scalability, addressing the growing demand for enhanced data throughput across various sectors, including financial services, government, media, and research. Founded in 2011 and headquartered in San Jose, California, Pavilion Data Systems also maintains offices in Schiphol, the Netherlands, and Pune, India.
Light Field Lab, Inc. is a technology startup focused on developing holographic capture display systems. Founded in 2017 and based in San Jose, California, the company creates innovative solutions that generate three-dimensional holographic images that can be viewed from multiple angles without the need for head-mounted devices. Its technology aims to project 3D holograms into living spaces, allowing users to experience immersive visuals that respond dynamically to their viewpoint. Additionally, Light Field Lab offers integrated processing and imaging solutions designed to deliver these visuals over commercial network speeds. The company is also working on a universal application programming interface to facilitate the adaptation of existing content for its holographic displays. With a mission to enable a holographic future, Light Field Lab seeks to unlock new business opportunities across both consumer and enterprise markets.
Frequency Therapeutics is a clinical-stage biotechnology company based in Woburn, Massachusetts, dedicated to leveraging the body's natural biology to repair or reverse damage from various degenerative diseases. The company employs a unique Progenitor Cell Activation approach, utilizing combinations of small molecules to stimulate progenitor cells to regenerate functional tissue. Its lead product candidate, FX-322, is currently undergoing phase 2a clinical trials aimed at addressing the underlying causes of sensorineural hearing loss. In addition to hearing loss, Frequency Therapeutics is developing therapies for a variety of degenerative conditions, including multiple sclerosis and ailments affecting muscle, skin, gastrointestinal tract, and bone health. The company has also established a collaboration agreement with Astellas Pharma for the development and commercialization of FX-322. Founded in 2014, Frequency Therapeutics is focused on disease modification through innovative therapeutic strategies.
Touché Solutions(formerly known as Mechavision), mainly manufactures robot sensor modules, and its developed plug-in robot haptic technology products have been used in Qisda's human-machine collaboration production line.
Ambiq Micro is an early-stage fabless semiconductor company that is developing ultra-low-power mixed-signal solutions for a new generation of wireless electronics.
Ambiq Micro was founded in 2010 on the simple yet powerful notion that extremely low power semiconductors are the key to the future of electronics. Through the use of their pioneering ultra-low-power technology, they help innovative companies around the world develop differentiated solutions that reduce or eliminate the need for batteries, lower overall system power, and maximize industrial design flexibility.
Frequency Therapeutics is a clinical-stage biotechnology company based in Woburn, Massachusetts, dedicated to leveraging the body's natural biology to repair or reverse damage from various degenerative diseases. The company employs a unique Progenitor Cell Activation approach, utilizing combinations of small molecules to stimulate progenitor cells to regenerate functional tissue. Its lead product candidate, FX-322, is currently undergoing phase 2a clinical trials aimed at addressing the underlying causes of sensorineural hearing loss. In addition to hearing loss, Frequency Therapeutics is developing therapies for a variety of degenerative conditions, including multiple sclerosis and ailments affecting muscle, skin, gastrointestinal tract, and bone health. The company has also established a collaboration agreement with Astellas Pharma for the development and commercialization of FX-322. Founded in 2014, Frequency Therapeutics is focused on disease modification through innovative therapeutic strategies.
AEye, Inc. specializes in developing vision hardware, software, and algorithms tailored for autonomous vehicles. The company is known for its innovative iDAR platform, which integrates LiDAR, computer vision, and artificial intelligence to enhance perception and motion planning for advanced driver assistance systems (ADAS) and autonomous vehicles. AEye's product offerings include the 4Sight A and 4Sight M sensors, as well as the AE100 Robotic Perception System and AE200, which are designed to meet the demands of the mobility market with modular and high-performance features. Since its inception in 2013 and a name change in 2016, AEye has established itself as a leader in intelligent sensing technology, securing investment from prestigious firms such as Kleiner Perkins and Intel Capital. The company is headquartered in Dublin, California, within the San Francisco Bay Area.
Cognito Health focuses on enhancing the healthcare environment by delivering value to both patients and healthcare systems. The company has developed a global healthcare device that employs predictive algorithms to monitor patients continuously, providing a data-driven, contact-free solution. This technology alerts healthcare professionals to potential patient safety issues before they arise, such as the need for repositioning to prevent pressure-related injuries. By visually mapping pressure points, Cognito Health enables clinicians to respond proactively, improving patient outcomes and optimizing care delivery.
Ambiq Micro is an early-stage fabless semiconductor company that is developing ultra-low-power mixed-signal solutions for a new generation of wireless electronics.
Ambiq Micro was founded in 2010 on the simple yet powerful notion that extremely low power semiconductors are the key to the future of electronics. Through the use of their pioneering ultra-low-power technology, they help innovative companies around the world develop differentiated solutions that reduce or eliminate the need for batteries, lower overall system power, and maximize industrial design flexibility.